Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Karyotyping01:17

Karyotyping

Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.A Simple Chromosome Staining Technique Provides Valuable Scientific InsightSome genetic diseases can be detected by looking at...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recognizing and managing linear morphea in a pediatric patient with skin of color.

International journal of women's dermatology·2026
Same author

Impact of Online vs In-Person Management of Atopic Dermatitis on Quality of Life and Access to Care: A Randomized Controlled Trial.

The Journal of investigative dermatology·2026
Same author

Online vs In-Person Care for Atopic Dermatitis: A Randomized Clinical Trial.

JAMA dermatology·2026
Same author

Comment on Rypka et al, "A single center retrospective cohort study of hydroxychloroquine-related adverse events in adults with lymphocytic cicatricial alopecia".

Journal of the American Academy of Dermatology·2026
Same author

Risk of ocular disease in congenital epidermal differentiation disorder patients: A propensity matched cohort analysis of the TriNetX database.

Journal of the American Academy of Dermatology·2026
Same author

Widespread Vesicles and Bullae in an 8-year-old With Atopic Dermatitis.

The Journal of emergency medicine·2026

Related Experiment Video

Updated: Jun 13, 2026

FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

Prenatal diagnosis of genodermatoses: current scope and future capabilities.

Minnelly Luu1, Julie L Cantatore-Francis, Sharon A Glick

  • 1Department of Dermatology, SUNY Downstate, Brooklyn, NY 11203, USA.

International Journal of Dermatology
|May 15, 2010
PubMed
Summary

Prenatal diagnosis for genodermatoses (inheritable skin diseases) has advanced significantly with DNA-based testing. These developments offer improved screening and management options for affected families.

More Related Videos

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
09:03

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

Related Experiment Videos

Last Updated: Jun 13, 2026

FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
09:03

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

Area of Science:

  • Medical Genetics
  • Dermatology
  • Molecular Biology

Background:

  • Genodermatoses are inheritable skin diseases associated with significant mortality and morbidity.
  • Historically, prenatal diagnosis relied on invasive fetal skin biopsy.
  • Advances in genetics and molecular biology have revolutionized diagnostic capabilities.

Purpose of the Study:

  • To review the evolution of prenatal diagnostic options for genodermatoses.
  • To highlight the impact of molecular advancements on prenatal testing.
  • To emphasize the importance of multidisciplinary care for patients with genodermatoses.

Main Methods:

  • Review of current literature on genodermatoses and prenatal diagnosis.
  • Analysis of advancements in DNA-based testing and non-invasive methods.
  • Discussion of the clinical implications for dermatologists and patient management.

Main Results:

  • DNA-based prenatal diagnosis is now available for a growing number of genodermatoses.
  • Newer, non-invasive prenatal testing methods are under development.
  • These advancements offer improved screening and diagnostic accuracy.

Conclusions:

  • Dermatologists must be aware of updated prenatal screening and testing options.
  • Multidisciplinary collaboration is crucial for optimal patient care in genodermatoses.
  • Future non-invasive techniques hold significant promise for early detection and management.